Eli Lilly's Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analystsProactive Investors • 04/21/26
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50Market Watch • 04/21/26
Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, OthersInvestors Business Daily • 04/20/26
Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisitionProactive Investors • 04/20/26
Will Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation?The Motley Fool • 04/20/26
Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ saysReuters • 04/19/26
These Alzheimer's drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.Market Watch • 04/18/26
LLY's Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes StudyZacks Investment Research • 04/17/26
Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied.Investors Business Daily • 04/17/26